GLS and hepatocellular carcinoma: Ginsenoside Rk1 suppressed ERK/c-Myc signaling, down-regulated glutaminase GLS1, and decreased glutathione production, which stimulates ROS and apoptosis in hepatocellular carcinoma [318].